Connective Capital Management LLC Buys Shares of 20,291 Vital Farms, Inc. $VITL

Key Points

• Connective Capital Management LLC acquired 20,291 shares of Vital Farms, Inc. ($VITL) in the first quarter, representing approximately $618,000 and making it the fund's 26th largest position.
• Multiple institutional investors have notably increased their stakes in Vital Farms, with 98.59% of the company's stock currently owned by institutional investors and hedge funds.
• Vital Farms has a consensus rating of "Buy" among analysts, with a target price ranging from $48.20 to $60.00, following a strong quarterly earnings report that exceeded revenue and earnings expectations.

Connective Capital Management LLC bought a new stake in Vital Farms, Inc. (NASDAQ:VITL - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 20,291 shares of the company's stock, valued at approximately $618,000. Vital Farms accounts for about 0.6% of Connective Capital Management LLC's portfolio, making the stock its 26th largest position.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd grew its stake in Vital Farms by 20,650.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock valued at $51,000 after acquiring an additional 1,652 shares during the period. US Bancorp DE lifted its holdings in shares of Vital Farms by 36.2% in the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock valued at $59,000 after purchasing an additional 513 shares in the last quarter. CWM LLC lifted its holdings in shares of Vital Farms by 43.2% in the first quarter. CWM LLC now owns 2,154 shares of the company's stock valued at $66,000 after purchasing an additional 650 shares in the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of Vital Farms in the first quarter valued at about $112,000. Finally, Comerica Bank lifted its holdings in shares of Vital Farms by 63.2% in the first quarter. Comerica Bank now owns 4,049 shares of the company's stock valued at $123,000 after purchasing an additional 1,568 shares in the last quarter. 98.59% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on VITL. Lake Street Capital set a $60.00 price target on Vital Farms and gave the company a "buy" rating in a report on Friday, August 8th. BMO Capital Markets restated an "outperform" rating on shares of Vital Farms in a report on Friday, August 8th. Mizuho boosted their price target on Vital Farms from $45.00 to $53.00 and gave the company an "outperform" rating in a report on Monday, August 11th. DA Davidson boosted their price target on Vital Farms from $51.00 to $52.00 and gave the company a "buy" rating in a report on Monday, August 11th. Finally, Stifel Nicolaus upped their target price on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Eleven investment analysts have rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $48.20.

Vital Farms Stock Performance

VITL opened at $50.94 on Monday. Vital Farms, Inc. has a 52-week low of $27.91 and a 52-week high of $51.55. The firm has a market capitalization of $2.28 billion, a PE ratio of 45.48 and a beta of 0.94. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.10 and a current ratio of 2.48. The business's 50-day simple moving average is $39.84 and its 200 day simple moving average is $35.32.

Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.09. The firm had revenue of $184.77 million for the quarter, compared to the consensus estimate of $170.28 million. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%.The business's revenue was up 25.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.36 earnings per share. Vital Farms has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Vital Farms news, CFO Thilo Wrede sold 1,200 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $31.93, for a total transaction of $38,316.00. Following the transaction, the chief financial officer owned 57,117 shares of the company's stock, valued at $1,823,745.81. The trade was a 2.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Stephanie Coon sold 10,005 shares of the business's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $46.15, for a total value of $461,730.75. Following the transaction, the senior vice president directly owned 45,779 shares in the company, valued at approximately $2,112,700.85. This trade represents a 17.94% decrease in their position. The disclosure for this sale can be found here. Insiders sold 94,905 shares of company stock worth $3,685,646 in the last three months. 21.30% of the stock is owned by corporate insiders.

Vital Farms Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.